IMARC Group, a leading market research company, has recently releases report titled “DNA Methylation Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2023-2028.” The study provides a detailed analysis of the industry, including the global DNA methylation market share, size, trends, and growth forecasts. The report also includes competitor and regional analysis and highlights the latest advancements in the market.
Report Highlights
How big is the DNA methylation market?
| Report Attributes | Details |
| Market Size in 2022 | US$ 1.30 Billion |
| Market Forecast in 2028 | US$ 2.93 Billion |
| Growth rate (2023 to 2028) | CAGR of 14.60% |
| Base Year of the Analysis | 2022 |
| Forecast Period | 2023-2028 |
What is DNA methylation?
Deoxyribonucleic acid (DNA) methylation is a cellular mechanism for controlling gene expression, an epigenetic process. It involves adding a methyl group (CH3) to the 5’ position of the cytosine, followed by guanine in the DNA sequence. It is utilized in plants to manipulate gene expression and develop new plant varieties with improved yield, disease resistance, and tolerance to environmental stresses. At present, DNA methylation finds extensive applications in laboratories for studying biological systems and evolving different species due to its versatility.
Request for a free sample copy of this report: https://www.imarcgroup.com/dna-methylation-market/requestsample
What are the growth prospects and trends in the DNA methylation?
The global DNA methylation market is primarily driven by the rising incidence of chronic diseases, including cancer, diabetes, hypertension, arthritis, Alzheimer’s disease, and cardiovascular diseases (CVDs). Moreover, the surging adoption of DNA methylation as a biomarker for identifying epigenetic changes associated with certain conditions, as it allows early detection of diseases, improves patient outcomes and reduces healthcare costs, is positively influencing the market growth. Additionally, expanding geriatric population, which is more prone to developing chronic conditions, has catalyzed the market growth.
Furthermore, the rising use of DNA methylation as a non-invasive diagnostic tool, which helps enhance patient comfort and reduce the risk of complications, is contributing to the market growth. Other factors, including ongoing research and development (R&D) activities, increasing utilization of DNA methylation in developing new plant varieties, and rising healthcare expenditures, are also anticipated to propel the market growth.
What is included in market segmentation?
The report has segmented the market into the following categories:
Product Insights:
- Consumables
- Kits and Reagents
- Enzymes
- Instrument and Software
Technology Insights:
- Polymerase Chain Reaction (PCR)
- Microarray
- Sequencing
- Others
Application Insights:
- Gene Therapy
- Clinical Research
- Diagnostics
- Others
End User Insights:
- Hospital and Diagnostic Laboratories
- Pharmaceutical and Biotechnology Companies
- Research and Academia
Breakup by Geography:
- North America (United States, Canada)
- Asia Pacific (China, Japan, India, South Korea, Australia, Indonesia, Others)
- Europe (Germany, France, United Kingdom, Italy, Spain, Russia, Others)
- Latin America (Brazil, Mexico, Others)
- Middle East and Africa
Who are the key players operating in the industry?
The report covers the major market players including:
- Abcam plc.
- Active Motif Inc.
- Diagenode S.A. (Hologic Inc.)
- EpiGentek Group Inc.
- Illumina Inc.
- Merck KGaA
- New England Biolabs Inc.
- PerkinElmer Inc.
- Qiagen N.V.
- Thermo-Fisher Scientific Inc.
- Zymo Research Corporation
Ask Analyst for Customization and Browse full report with TOC & List of Figure: https://www.imarcgroup.com/request?type=report&id=6890&flag=C
If you require any specific information that is not covered currently within the scope of the report, we will provide the same as a part of the customization.
About Us
IMARC Group is a leading market research company that offers management strategy and market research worldwide. We partner with clients in all sectors and regions to identify their highest-value opportunities, address their most critical challenges, and transform their businesses.
IMARC Group’s information products include major market, scientific, economic and technological developments for business leaders in pharmaceutical, industrial, and high technology organizations. Market forecasts and industry analysis for biotechnology, advanced materials, pharmaceuticals, food and beverage, travel and tourism, nanotechnology and novel processing methods are at the top of the company’s expertise.
Contact US
IMARC Group
134 N 4th St. Brooklyn, NY 11249, USA
USA: +1-631-791-1145 | Asia: +91-120-433-0800
Email: sales@imarcgroup.com
Follow us on Twitter: @imarcglobal
LinkedIn: https://www.linkedin.com/company/imarc-group/mycompany/
